Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
March 30, 2017
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders
John R Hurst, Nisha Verma, David Lowe, et al.
Thorax
|
March 31, 2022
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19
Linzy Houchen-Wolloff, Krisnah Poinasamy, Kate Holmes, et al.
The European Respiratory Journal
|
November 16, 2023
Mortality surrogates in combined pulmonary fibrosis and emphysema
An Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 29, 2026
Longitudinal <sup>1</sup>H and <sup>129</sup>Xe Lung MRI in Patients With Post-COVID Residual Lung Abnormalities
Laura C Saunders, Guilhem J Collier, Laurie J Smith, et al.
Science Advances
|
May 8, 2026
The pleuroparenchymal fibroelastosis atlas reveals aberrant cell states and their zonation as an alternate roadmap to lung fibrosis
Jannik Ruwisch, Aurélie Cazes, Lena M Leiber, et al.
The Lancet. Respiratory Medicine
|
October 10, 2021
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
Rachael A Evans, Hamish McAuley, Ewen M Harrison, et al.
BMJ Open Respiratory Research
|
September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
Ebiomedicine
|
January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury
Iain Stewart, Joseph Jacob, Joanna C Porter, et al.
International Journal of Epidemiology
|
October 21, 2024
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Omer Elneima, Hamish J C McAuley, Olivia C Leavy, et al.
ERJ Open Research
|
October 1, 2024
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
Olivia C Leavy, Richard J Russell, Ewen M Harrison, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
The Journal of Allergy and Clinical Immunology. in Practice
|
March 30, 2017
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders
John R Hurst, Nisha Verma, David Lowe, et al.
Thorax
|
March 31, 2022
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19
Linzy Houchen-Wolloff, Krisnah Poinasamy, Kate Holmes, et al.
The European Respiratory Journal
|
November 16, 2023
Mortality surrogates in combined pulmonary fibrosis and emphysema
An Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 29, 2026
Longitudinal <sup>1</sup>H and <sup>129</sup>Xe Lung MRI in Patients With Post-COVID Residual Lung Abnormalities
Laura C Saunders, Guilhem J Collier, Laurie J Smith, et al.
Science Advances
|
May 8, 2026
The pleuroparenchymal fibroelastosis atlas reveals aberrant cell states and their zonation as an alternate roadmap to lung fibrosis
Jannik Ruwisch, Aurélie Cazes, Lena M Leiber, et al.
The Lancet. Respiratory Medicine
|
October 10, 2021
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
Rachael A Evans, Hamish McAuley, Ewen M Harrison, et al.
BMJ Open Respiratory Research
|
September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
Ebiomedicine
|
January 25, 2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury
Iain Stewart, Joseph Jacob, Joanna C Porter, et al.
International Journal of Epidemiology
|
October 21, 2024
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Omer Elneima, Hamish J C McAuley, Olivia C Leavy, et al.
ERJ Open Research
|
October 1, 2024
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
Olivia C Leavy, Richard J Russell, Ewen M Harrison, et al.
Page
of 19